Skip to main content English

Further Information

Our aims

B lymphocytes are immune cells that produce antibodies and provide long-lasting immunity. Although B cells are a major emerging therapeutic target in cancer and autoimmune rheumatological conditions, there are still substantial gaps in understanding how B cells can be harnessed to treat cardiovascular disease (CVD).




This project is a Transatlantic Network sponsored by the Leducq Foundation for Cardiovascular Disease